Navneet Majhail։ Binaytara Heme Summit’s Impact Pitch Session Offers $200,000 for Hematologic Malignancy Research
Navneet Majhail/LinkedIn

Navneet Majhail։ Binaytara Heme Summit’s Impact Pitch Session Offers $200,000 for Hematologic Malignancy Research

Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon, shared on LinkedIn:

“Innovative way to fund research for fellows and junior faculty!

Shark tank style Impact Pitch session at Binaytara Heme Summit in Nashville.

$200,000 on the line that will support foundational heme malignancy research for 3 junior faculty and 2 fellows.

The 9 finalists are making their ՛pitches՛ to four ՛catalysts՛ who will decide who gets the awards.

Very strong projects ranging from basic discovery science to clinical research.

Let’s go!”

To which Binay Shah, President of Binaytara, added:

“Great ideas – I’m loving this session.”

Navneet Majhail

Other articles about hematology-oncology and Binaytara on OncoDaily.